Amgen Analysts Sidelined After Q4 Report, Say Valuation Reflects Growth Potential By: TalkMarkets January 31, 2020 at 12:07 PM EST Amgen, Inc.'s disappointing 2020 EPS guidance issued Thursday spooked investors, leading to a pullback in the stock. Read More >> Related Stocks: Amgen